UHS Posts Strong Q2 Earnings, Net Income Jumps 9.3%

TL;DR

**UHS is crushing it with a 9.3% net income jump, making it a solid buy in the healthcare sector.**

AI Summary

UNIVERSAL HEALTH SERVICES INC (UHS) reported robust financial performance for the quarter ended June 30, 2025. Revenue increased to $3.78 billion for the three months ended June 30, 2025, up from $3.56 billion in the prior-year quarter, representing a 6.18% increase. Net income attributable to UHS increased to $285.6 million for the three months ended June 30, 2025, compared to $261.3 million for the same period in 2024, a rise of 9.3%. The company's acute care hospital services saw a revenue increase, with Managed Care revenue for acute care growing from $1.05 billion in Q2 2024 to $1.12 billion in Q2 2025. Behavioral health services also contributed positively, with Managed Care revenue for behavioral health increasing from $1.01 billion in Q2 2024 to $1.08 billion in Q2 2025. Key risks include ongoing litigation, such as the Pavilion Behavioral Health System case with potential punitive damages, and the general liability exposure for subsidiaries capped at $100 million per occurrence. Strategic outlook remains focused on managing these liabilities while continuing to grow revenue across both acute care and behavioral health segments, supported by strong managed care contracts.

Why It Matters

UHS's strong Q2 performance, particularly the 9.3% net income increase, signals robust demand for healthcare services and effective cost management, which is positive for investors. This growth, especially in managed care segments for both acute and behavioral health, suggests the company is successfully navigating the evolving healthcare landscape and competitive pressures from rivals like HCA Healthcare. For employees, continued financial health could mean job stability and potential growth opportunities. Customers benefit from a stable and expanding healthcare provider, while the broader market sees a key player demonstrating resilience and growth in a critical sector.

Risk Assessment

Risk Level: medium — The risk level is medium due to ongoing litigation, specifically the Pavilion Behavioral Health System case with potential punitive damages, and the general liability exposure for subsidiaries capped at $100 million per occurrence. While the company has a strong financial quarter, these legal and operational risks could impact future earnings and reputation.

Analyst Insight

Investors should consider UHS a strong contender in the healthcare sector given its impressive Q2 2025 financial results, particularly the 9.3% increase in net income. Monitor ongoing litigation risks, but the consistent growth in both acute care and behavioral health managed care revenue suggests a resilient business model.

Financial Highlights

revenue

$3.78B

net Income

$285.6M

revenue Growth

+6.18%

Revenue Breakdown

Key Numbers

• $3.78B — Total Revenue (for the three months ended June 30, 2025, up from $3.56 billion in Q2 2024)
• $285.6M — Net Income Attributable to UHS (for the three months ended June 30, 2025, up from $261.3 million in Q2 2024)
• 9.3% — Net Income Increase (year-over-year increase for Q2 2025)
• 6.18% — Revenue Increase (year-over-year increase for Q2 2025)
• $1.12B — Acute Care Managed Care Revenue (for Q2 2025, up from $1.05 billion in Q2 2024)
• $1.08B — Behavioral Health Managed Care Revenue (for Q2 2025, up from $1.01 billion in Q2 2024)
• $100M — General Liability Cap (maximum per occurrence for subsidiaries)

Key Players & Entities

• UNIVERSAL HEALTH SERVICES INC (company) — filer of the 10-Q
• The Pavilion Behavioral Health System (company) — involved in a punitive damages lawsuit
• Cumberland Hospital For Children And Adolescents (company) — involved in professional malpractice liability
• HCA Healthcare (company) — competitor in the healthcare market
• Premier Inc. (company) — mentioned in other operating income/expense
• Universal Health Realty Income Trust (company) — related entity
• SEC (regulator) — regulates financial filings
• Bloomberg (company) — financial news outlet

FAQ

Risk Factors

• Pavilion Behavioral Health System Litigation [high — legal]: The company faces potential punitive damages in the Pavilion Behavioral Health System case. This litigation represents a significant legal risk that could impact financial results if an unfavorable outcome occurs.
• General Liability Exposure [medium — legal]: Subsidiaries have general liability exposure capped at $100 million per occurrence. While capped, the frequency or severity of claims could still lead to substantial financial impact.
• Healthcare Regulatory Environment [medium — regulatory]: As a healthcare provider, UHS is subject to extensive federal, state, and local regulations. Changes in healthcare laws, reimbursement policies, or compliance failures can adversely affect operations and profitability.
• Staffing and Labor Costs [medium — operational]: The healthcare industry faces ongoing challenges with staffing shortages and rising labor costs. UHS's ability to attract and retain qualified personnel is critical for maintaining service quality and managing operating expenses.
• Managed Care Contract Renewals [medium — market]: A significant portion of UHS's revenue is derived from managed care contracts. The renewal of these contracts on favorable terms is crucial for continued revenue growth and profitability.

Industry Context

The healthcare services industry, particularly hospital operations, is characterized by evolving reimbursement models, increasing regulatory scrutiny, and a growing demand for both acute and behavioral health services. Companies like UHS operate in a competitive landscape where scale, efficiency, and strong managed care relationships are critical for success. The increasing focus on mental health is driving growth in the behavioral health segment.

Regulatory Implications

UHS operates under a complex web of healthcare regulations, including those related to patient care, billing, and data privacy. Compliance with these regulations is paramount, as violations can lead to significant fines, penalties, and reputational damage. Changes in government healthcare policy, such as Medicare and Medicaid reimbursement rates, can directly impact the company's financial performance.

What Investors Should Do

1. Monitor litigation developments
2. Assess managed care contract stability
3. Evaluate operational efficiency and cost management

Key Dates

• 2025-06-30: Quarter End Date — Represents the period for which the financial results in the 10-Q are reported, showing revenue of $3.78 billion and net income of $285.6 million.
• 2024-10-10: Pavilion Behavioral Health System Litigation — This date is associated with the Pavilion Behavioral Health System case, highlighting a significant legal risk with potential punitive damages.
• 2017-12-31: General Liability Cap Established — Indicates the establishment of the $100 million per occurrence cap for general liability for subsidiaries, a long-standing risk factor.

Glossary

Managed Care

A type of healthcare plan that contracts with medical providers to create a network of doctors, hospitals, and other healthcare professionals who agree to provide services to plan members at a negotiated rate. (A primary revenue driver for UHS, with significant contributions from both acute care and behavioral health segments.)

Acute Care Hospital Services

Hospital services that provide immediate, short-term medical care for acute illnesses or injuries. (A key operating segment for UHS, showing revenue growth in the reported quarter.)

Behavioral Health Services

Healthcare services focused on the diagnosis and treatment of mental health and substance use disorders. (Another core segment for UHS, demonstrating positive revenue trends.)

Punitive Damages

Damages awarded in a lawsuit to punish the defendant for malicious, fraudulent, or reckless conduct and to deter future wrongdoing. (A significant risk associated with the Pavilion Behavioral Health System litigation, potentially leading to substantial financial penalties.)

General Liability

Insurance coverage that protects a business against claims of bodily injury or property damage that occur on its premises or as a result of its operations. (A potential financial exposure for UHS's subsidiaries, with a specified per-occurrence cap.)

Year-Over-Year Comparison

Compared to the prior year's quarter, Universal Health Services Inc. has demonstrated solid growth, with total revenue increasing by 6.18% to $3.78 billion and net income attributable to UHS rising by 9.3% to $285.6 million. Both acute care and behavioral health segments, particularly their managed care revenue streams, have shown positive year-over-year increases. While the company continues to manage its existing legal risks, such as the Pavilion Behavioral Health System case and general liability exposure, the financial performance indicates a strong operational execution in the current reporting period.

Key Financial Figures

• $0.01 — hich registered Class B Common Stock, $0.01 par value UHS New York Stock Exchan

Filing Documents

• uhs-20250630.htm (10-Q) — 5380KB
• uhs-ex22_1.htm (EX-22.1) — 1051KB
• uhs-ex31_1.htm (EX-31.1) — 11KB
• uhs-ex31_2.htm (EX-31.2) — 10KB
• uhs-ex32_1.htm (EX-32.1) — 7KB
• uhs-ex32_2.htm (EX-32.2) — 7KB
• 0000950170-25-105857.txt ( ) — 16091KB
• uhs-20250630.xsd (EX-101.SCH) — 1507KB
• uhs-20250630_htm.xml (XML) — 2769KB

FINANCIAL INFORMATION

PART I. FINANCIAL INFORMATION

Financial Statements (unaudited)

Item 1. Financial Statements (unaudited) Condensed Consolidated Statements of Income – Three and Six Months Ended June 30, 2025 and 2024 3 Condensed Consolidated Statements of Comprehensive Income – Three and Six Months Ended June 30, 2025 and 2024 4 Condensed Consolidated Balance Sheets – June 30, 2025 and December 31, 2024 5 Condensed Consolidated Statements of Changes in Equity – Three and Six Months Ended June 30, 2025 and 2024 6 Condensed Consolidated Statements of Cash Flows - Six Months Ended June 30, 2025 and 2024 8 Notes to Condensed Consolidated Financial Statements 9

Management's Discussion and Analysis of Financial Condition and Results of Operations

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 28

Quantitative and Qualitative Disclosures About Market Risk

Item 3. Quantitative and Qualitative Disclosures About Market Risk 65

Controls and Procedures

Item 4. Controls and Procedures 65

Other Information

PART II. Other Information

Legal Proceedings

Item 1. Legal Proceedings 66

Risk Factors

Item 1A. Risk Factors 66

Unregistered Sales of Equity Securities and Use of Proceeds

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 66

Other Information

Item 5. Other Information 67

Exhibits

Item 6. Exhibits 68

Signatures

Signatures 69 This Quarterly Report on Form 10-Q is for the quarter ended June 30, 2025. This Report modifies and supersedes documents filed prior to this Report. Information that we file with the Securities and Exchange Commission (the "SEC") in the future will automatically update and supersede information contained in this Report. In this Quarterly Report, "we," "us," "our" "UHS" and the "Company" refer to Universal Health Services, Inc. and its subsidiaries. UHS is a registered trademark of UHS of Delaware, Inc., the management company for, and a wholly-owned subsidiary of Universal Health Services, Inc. Universal Health Services, Inc. is a holding company and operates through its subsidiaries including its management company, UHS of Delaware, Inc. All healthcare and management operations are conducted by subsidiaries of Universal Health Services, Inc. To the extent any reference to "UHS" or "UHS facilities" in this report including letters, narratives or other forms contained herein relates to our healthcare or management operations it is referring to Universal Health Services, Inc.'s subsidiaries including UHS of Delaware, Inc. Further, the terms "we," "us," "our" or the "Company" in such context similarly refer to the operations of Universal Health Services Inc.'s subsidiaries including UHS of Delaware, Inc. Any reference to employees or employment contained herein refers to employment with or employees of the subsidiaries of Universal Health Services, Inc. including UHS of Delaware, Inc. 2

FINANCI AL INFORMATION

PART I. FINANCI AL INFORMATION UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF INCOME (amounts in thousands, except per share amounts) (unaudited) Three months ended June 30, Six months ended June 30, 2025 2024 2025 2024 Net revenues $ 4,283,816 $ 3,907,604 $ 8,383,536 $ 7,751,186 Operating charges: Salaries, wages and benefits 2,014,951 1,856,372 3,966,055 3,698,996 Other operating expenses 1,162,566 1,043,116 2,268,318 2,075,286 Supplies expense 418,785 388,063 821,666 791,636 Depreciation and amortization 152,004 147,480 300,349 288,483 Lease and rental expense 35,240 36,175 72,053 71,625 3,783,546 3,471,206 7,428,441 6,926,026 Income from operations 500,270 436,398 955,095 825,160 Interest expense, net 35,364 48,899 75,420 101,725 Other (income) expense, net ( 8,479 ) 5,493 ( 14,138 ) 5,343 Income before income taxes 473,385 382,006 893,813 718,092 Provision for income taxes 110,773 87,676 209,573 157,940 Net income 362,612 294,330 684,240 560,152 Less: Net income (loss) attributable to noncontrolling interests 9,394 5,178 14,342 9,166 Net income attributable to UHS $ 353,218 $ 289,152 $ 669,898 $ 550,986 Basic earnings per share attributable to UHS $ 5.49 $ 4.32 $ 10.36 $ 8.22 Diluted earnings per share attributable to UHS $ 5.43 $ 4.26 $ 10.23 $ 8.08 Weighted average number of common shares - basic 64,356 66,878 64,663 67,041 Add: Other share equivalents 635 1,042 851 1,160 Weighted average number of common shares and equivalents - diluted 64,991 67,920 65,514 68,201 The accompanying notes are an integral part of these condensed consolidated financial statements. 3 UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEM ENTS OF COMPREHENSIV

View Full Filing

View this 10-Q filing on SEC EDGAR